Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The potential of baicalin to enhance neuroprotection and mitochondrial function in a human neuronal cell model.

Autor: Liu ZSJ; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, 3220, Australia. zoe.liu@deakin.edu.au., Truong TTT; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, 3220, Australia., Bortolasci CC; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, 3220, Australia., Spolding B; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, 3220, Australia., Panizzutti B; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, 3220, Australia., Swinton C; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, 3220, Australia., Kim JH; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, 3220, Australia.; Florey Institute of Neuroscience and Mental Health, Parkville, 3010, Australia., Hernández D; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, 3220, Australia., Kidnapillai S; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, 3220, Australia., Gray L; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, 3220, Australia., Berk M; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, 3220, Australia.; Florey Institute of Neuroscience and Mental Health, Parkville, 3010, Australia., Dean OM; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, 3220, Australia.; Florey Institute of Neuroscience and Mental Health, Parkville, 3010, Australia., Walder K; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, 3220, Australia.

Publikováno v: Molecular psychiatry [Mol Psychiatry] 2024 Aug; Vol. 29 (8), pp. 2487-2495. Date of Electronic Publication: 2024 Mar 19.

Network-based drug repurposing for schizophrenia.

Autor: Truong TTT; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Australia., Liu ZSJ; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Australia., Panizzutti B; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Australia., Kim JH; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Australia.; Florey Institute of Neuroscience and Mental Health, Parkville, Australia., Dean OM; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Australia.; Florey Institute of Neuroscience and Mental Health, Parkville, Australia., Berk M; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Australia.; Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, The Florey Institute for Neuroscience and Mental Health and the Department of Psychiatry, University of Melbourne, Parkville, 3010, Australia., Walder K; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Australia. ken.walder@deakin.edu.au.

Publikováno v: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2024 May; Vol. 49 (6), pp. 983-992. Date of Electronic Publication: 2024 Feb 06.

Use of a gene expression signature to identify trimetazidine for repurposing to treat bipolar depression.

Autor: Bortolasci CC; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia., Kidnapillai S; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia., Spolding B; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia., Truong TTT; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia., Connor T; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia., Swinton C; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia., Panizzutti B; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia., Liu ZSJ; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia., Sanigorski A; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia., Dean OM; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia.; The Florey Institute of Neuroscience and Mental Health, Parkville, Australia., Crowley T; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia.; Bioinformatics Core Research Facility (BCRF), Deakin University, Geelong, Australia., Richardson M; Bioinformatics Core Research Facility (BCRF), Deakin University, Geelong, Australia., Bozaoglu K; Murdoch Children's Research Institute, Parkville, Victoria, Australia.; Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia., Vlahos K; Murdoch Children's Research Institute, Parkville, Victoria, Australia., Cowdery S; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia., Watmuff B; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia., Steyn SF; Centre of Excellence for Pharmaceutical Sciences, Faculty of Health Sciences, North-West University, Potchefstroom, South Africa., Wolmarans W; Centre of Excellence for Pharmaceutical Sciences, Faculty of Health Sciences, North-West University, Potchefstroom, South Africa., Engelbrecht BJ; Centre of Excellence for Pharmaceutical Sciences, Faculty of Health Sciences, North-West University, Potchefstroom, South Africa., Perry C; The Florey Institute of Neuroscience and Mental Health, Parkville, Australia., Drummond K; The Florey Institute of Neuroscience and Mental Health, Parkville, Australia., Pang T; The Florey Institute of Neuroscience and Mental Health, Parkville, Australia., Jamain S; Univ Paris Est Créteil, INSERM, IMRB, Translational Neuropsychiatry, AP-HP, DMU IMPACT, FHU ADAPT, Fondation FondaMental, Créteil, France., Gray L; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia.; The Florey Institute of Neuroscience and Mental Health, Parkville, Australia., McGee SL; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia., Harvey BH; Centre of Excellence for Pharmaceutical Sciences, Faculty of Health Sciences, North-West University, Potchefstroom, South Africa.; SAMRC Unit on Risk and Resilience in Mental Disorders, Department of Psychiatry and Mental Health and Neuroscience Institute, University of Cape Town, Cape Town, South Africa., Kim JH; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia.; The Florey Institute of Neuroscience and Mental Health, Parkville, Australia., Leboyer M; Univ Paris Est Créteil, INSERM, IMRB, Translational Neuropsychiatry, AP-HP, DMU IMPACT, FHU ADAPT, Fondation FondaMental, Créteil, France., Berk M; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia.; The Florey Institute of Neuroscience and Mental Health, Parkville, Australia.; Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, Australia., Walder K; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia.

Publikováno v: Bipolar disorders [Bipolar Disord] 2023 Dec; Vol. 25 (8), pp. 661-670. Date of Electronic Publication: 2023 Mar 23.